Search Results 1671-1680 of 16648 for vitamin toxicity

  1. Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors - Mayo Clinic

    ... toxicity lasting greater than 6 weeks. -Received prior systemic anticancer therapy within 4 weeks prior to study treatment. -Received prior radiotherapy ...

  2. Publications - David L. Murray, M.D., Ph.D. - Mayo Clinic

    Peripheral neuropathy associated with silver toxicity. Neurology. 2019 Mar 5; 92 (10):481-483 Epub 2019 Feb 01. View PubMed; He L, Anderson LC, Barnidge DR ...

  3. Publications - Elizabeth R. Vogel, M.D., Ph.D. - Mayo Clinic

    Vitamin D attenuates cytokine-induced remodeling in human fetal airway smooth muscle cells. J Cell Physiol. 2015 Jun; 230 (6):1189-98. View PubMed; Vogel ER ...

  4. Health Topics - Mayo Clinic News Network

    8 common questions new parents ask about vitamin K featured image. Health & Wellness. 8 common questions new parents ask about vitamin K. Mayo Clinic Staff.

  5. ... (vitamin K1) 5 mg tablet,84.9 8709,637000000,60687038194,phytonadione (vitamin K1) 5 mg tablet,97.53 8723,637000000,904688210,phytonadione (vitamin K1) 5 mg ...

  6. Do infrared saunas have any health benefits? - Mayo Clinic

    A regular sauna uses heat to warm the air, which in turn warms your body. An infrared sauna heats your body directly without warming the air around you.

  7. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

    Vitamin E treatment (≥800 IU/day) must not have been initiated after the qualifying liver biopsy was performed. Age and reproductive status: Men or women ...

  8. Combination Vaccine Immunotherapy (DRibbles) for Patients with Definitively-treated Stage III Non-small Cell Lung Cancer - Mayo Clinic

    Toxicities from definitive therapy resolved to less than grade 1; ECOG performance status 0-1; Negative pregnancy test in women of childbearing potential ...

  9. Expanded Access Program (EAP): Allow Patients in the US with Idiopathic Pulmonary Fibrosis Access to Pirfenidone - Mayo Clinic

    Known explanation for interstitial lung disease other than IPF, including but not limited to radiation, drug toxicity, sarcoidosis, hypersensitivity ...

  10. Patient Reported Outcomes of Nontuberculous Mycobacterial Pulmonary Disease - Mayo Clinic

    ... toxicity and tolerability using patient-reported symptomatic adverse events in treated patients with nontuberculous mycobacterial pulmonary disease (NTM-PD).